BACKGROUND: Human heart failure (HF) increases alternative mRNA splicing of the type V, voltage-gated cardiac Na+ channel α-subunit (SCN5A), generating variants encoding truncated, nonfunctional channels that are trapped in the endoplasmic reticulum. In this work, we tested whether truncated Na+ channels activate the unfolded protein response (UPR), contributing to SCN5A electric remodeling in HF. METHODS AND RESULTS: UPR and SCN5A were analyzed in human ventricular systolic HF tissue samples and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Cells were exposed to angiotensin II (AngII) and hypoxia, known activators of abnormal SCN5A mRNA splicing, or were induced to overexpress SCN5A variants. UPR effectors, protein kinase R-like ER kinase (PERK), calreticulin, and CHOP, were increased in human HF tissues. Induction of SCN5A variants with AngII or hypoxia or the expression of exogenous variants induced the UPR with concomitant downregulation of Na+ current. PERK activation destabilized SCN5A and, surprisingly, Kv4.3 channel mRNAs but not transient receptor potential cation channel M7 (TRPM7) channel mRNA. PERK inhibition prevented the loss of full-length SCN5A and Kv4.3 mRNA levels resulting from expressing Na+ channel mRNA splice variants. CONCLUSIONS: UPR can be initiated by Na+ channel mRNA splice variants and is involved in the reduction of cardiac Na+ current during human HF. Because the effect is not entirely specific to the SCN5A transcript, the UPR may play an important role in downregulation of multiple cardiac genes in HF.
BACKGROUND:Humanheart failure (HF) increases alternative mRNA splicing of the type V, voltage-gated cardiac Na+ channel α-subunit (SCN5A), generating variants encoding truncated, nonfunctional channels that are trapped in the endoplasmic reticulum. In this work, we tested whether truncated Na+ channels activate the unfolded protein response (UPR), contributing to SCN5A electric remodeling in HF. METHODS AND RESULTS: UPR and SCN5A were analyzed in humanventricular systolic HF tissue samples and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Cells were exposed to angiotensin II (AngII) and hypoxia, known activators of abnormal SCN5A mRNA splicing, or were induced to overexpress SCN5A variants. UPR effectors, protein kinase R-like ER kinase (PERK), calreticulin, and CHOP, were increased in human HF tissues. Induction of SCN5A variants with AngII or hypoxia or the expression of exogenous variants induced the UPR with concomitant downregulation of Na+ current. PERK activation destabilized SCN5A and, surprisingly, Kv4.3 channel mRNAs but not transient receptor potential cation channel M7 (TRPM7) channel mRNA. PERK inhibition prevented the loss of full-length SCN5A and Kv4.3 mRNA levels resulting from expressing Na+ channel mRNA splice variants. CONCLUSIONS: UPR can be initiated by Na+ channel mRNA splice variants and is involved in the reduction of cardiac Na+ current during human HF. Because the effect is not entirely specific to the SCN5A transcript, the UPR may play an important role in downregulation of multiple cardiac genes in HF.
Authors: Eva Szegezdi; Angela Duffy; Martin E O'Mahoney; Susan E Logue; Louise A Mylotte; Timothy O'brien; Afshin Samali Journal: Biochem Biophys Res Commun Date: 2006-09-12 Impact factor: 3.575
Authors: Jochen Rose; Antonis A Armoundas; Yanli Tian; Deborah DiSilvestre; Miroslava Burysek; Victoria Halperin; Brian O'Rourke; David A Kass; Eduardo Marbán; Gordon F Tomaselli Journal: Am J Physiol Heart Circ Physiol Date: 2005-01-06 Impact factor: 4.733
Authors: Carmen R Valdivia; William W Chu; Jielin Pu; Jason D Foell; Robert A Haworth; Mathew R Wolff; Timothy J Kamp; Jonathan C Makielski Journal: J Mol Cell Cardiol Date: 2005-03 Impact factor: 5.000
Authors: András Rab; Rafal Bartoszewski; Asta Jurkuvenaite; John Wakefield; James F Collawn; Zsuzsa Bebok Journal: Am J Physiol Cell Physiol Date: 2006-09-20 Impact factor: 4.249
Authors: Jianhua Zhang; Matthew Klos; Gisela F Wilson; Amanda M Herman; Xiaojun Lian; Kunil K Raval; Matthew R Barron; Luqia Hou; Andrew G Soerens; Junying Yu; Sean P Palecek; Gary E Lyons; James A Thomson; Todd J Herron; José Jalife; Timothy J Kamp Journal: Circ Res Date: 2012-08-21 Impact factor: 17.367
Authors: Jennifer F Raven; Dionissios Baltzis; Shuo Wang; Zineb Mounir; Andreas I Papadakis; Hong Qing Gao; Antonis E Koromilas Journal: J Biol Chem Date: 2007-12-06 Impact factor: 5.157
Authors: Lijuan L Shang; Arnold E Pfahnl; Shamarendra Sanyal; Zhe Jiao; Jon Allen; Kathrin Banach; John Fahrenbach; Daiana Weiss; W Robert Taylor; A Maziar Zafari; Samuel C Dudley Journal: Circ Res Date: 2007-09-27 Impact factor: 17.367
Authors: A Burgeiro; A C Fonseca; D Espinoza; L Carvalho; N Lourenço; M Antunes; E Carvalho Journal: Biochim Biophys Acta Mol Basis Dis Date: 2018-04-04 Impact factor: 5.187
Authors: Adam M Noyes; Anyu Zhou; Ge Gao; Lianzhi Gu; Sharlene Day; J Andrew Wasserstrom; Samuel C Dudley Journal: Int J Cardiol Date: 2017-09-07 Impact factor: 4.164
Authors: Debasree Banerjee; Tom N Grammatopoulos; Amy Palmisciano; James R Klinger; Ipsita Krishnan; Mary Whittenhall; Anyu Zhou; Samuel Dudley; Corey E Ventetuolo Journal: Chest Date: 2020-02-26 Impact factor: 9.410
Authors: Brian C Jensen; Scott J Bultman; Darcy Holley; Wei Tang; Gustaaf de Ridder; Salvatore Pizzo; Dawn Bowles; Monte S Willis Journal: Int J Clin Exp Med Date: 2017-01-30
Authors: Ge Gao; Vikram Brahmanandam; Mihai Raicu; Lianzhi Gu; Li Zhou; Srinivasan Kasturirangan; Anish Shah; Smita I Negi; Melissa R Wood; Ankit A Desai; Antone Tatooles; Alan Schwartz; Samuel C Dudley Journal: J Am Coll Cardiol Date: 2014-04-02 Impact factor: 24.094
Authors: Man Liu; Guangbin Shi; Anyu Zhou; Cassady E Rupert; Kareen L K Coulombe; Samuel C Dudley Journal: J Mol Cell Cardiol Date: 2018-02-21 Impact factor: 5.000